https://scholars.lib.ntu.edu.tw/handle/123456789/469962
標題: | Local Control and Clinical Outcome of High-risk Pediatric Neuroblastoma Patients after Receiving Multimodality Treatment and Helical Tomotherapy | 作者: | Chen G.-Y. CHIA-HSIEN CHENG YU-HSUAN CHEN MENG-YAO LU HSIU-HAO CHANG YUNG-LI YANG SHIANN-TANG JOU WEN-MING HSU SUNG-HSIN KUO |
公開日期: | 2019 | 出版社: | International Institute of Anticancer Research | 卷: | 39 | 期: | 4 | 起(迄)頁: | 2207-2215 | 來源出版物: | Anticancer Research | 摘要: | Background/Aim: The local control and clinical outcome of pediatric patients with high-risk neuroblastoma treated with tomotherapy as part of a modern multimodality paradigm was assessed. Patients and Methods: Twenty-four high-risk neuroblastoma patients who received radiotherapy (RT) to the primary site using helical tomotherapy (median 21.6 Gy) were included. Local failure (LF) was correlated with biological and clinical prognostic factors. Event-free survival (EFS) and overall survival (OS) were estimated using Kaplan-Meier analysis. Results: After a median followup of 43.5 months, the 3-year cumulative incidence of LF, EFS, and OS were 21.1%, 45.8%, and 62.9%, respectively. Elevated serum lactate dehydrogenase ?1,500 U/l was associated with worse LF (p=0.02). There was no 3-year LF noted for patients with gross residual disease (GRD) who received more than 21.6 Gy. Conclusion: We demonstrated favorable local control of tomotherapy for the treatment of high-risk neuroblastoma. Dose escalation of RT for patients with GRD should be investigated. ? 2019 International Institute of Anticancer Research. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064487425&doi=10.21873%2fanticanres.13336&partnerID=40&md5=9e22113c0202c29bc42d6824c4ba234f https://scholars.lib.ntu.edu.tw/handle/123456789/469962 |
ISSN: | 0250-7005 | DOI: | 10.21873/anticanres.13336 | SDG/關鍵字: | lactate dehydrogenase; antineoplastic agent; lactate dehydrogenase; adolescent; Article; child; clinical article; clinical outcome; dermatitis; distant metastasis; event free survival; female; follow up; growth inhibition; high risk patient; histopathology; human; lactate dehydrogenase blood level; lymph node dissection; male; minimal residual disease; nausea and vomiting; neuroblastoma; neutropenia; overall survival; primary tumor; priority journal; radiation dose; thrombocytopenia; tomotherapy; treatment interruption; tumor recurrence; blood; hematopoietic stem cell transplantation; infant; intensity modulated radiation therapy; Kaplan Meier method; multimodality cancer therapy; neuroblastoma; preschool child; prognosis; risk; treatment outcome; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Male; Neuroblastoma; Prognosis; Radiotherapy, Intensity-Modulated; Risk; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。